C1QTNF9 and atherosclerosis: CTRP9 demonstrated significant protective effects against atherosclerosis, including enhancing plaque stability by activating AMPK, inhibiting levels of adhesion molecules in atherosclerotic plaques, and reducing MCP-1 and TNF-α secretion.